Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis - Related Studies

Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis

This study has been completed.

Study NCT00004748. Last updated on June 23, 2005. Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Liver Cirrhosis, Biliary

2	Additional conditions recognized in this trial
		Fibrosis
		Liver Cirrhosis

3	More general conditions related to this trial
		Bile Duct Diseases
		Biliary Tract Diseases
		Cholestasis
		Cholestasis, Intrahepatic
		Digestive System Diseases
		Liver Diseases
		Pathologic Processes

4	Interventions listed in this trial
		colchicine
		methotrexate
		ursodiol

5	More general drug interventions related to this trial
		Abortifacient Agents
		Abortifacient Agents, Nonsteroidal
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antimitotic Agents
		Antineoplastic Agents
		Antirheumatic Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Gout Suppressants
		Immunologic Factors
		Immunosuppressive Agents
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Therapeutic Uses
		Tubulin Modulators

6	Sponsors listed in this trial
		National Center for Research Resources (NCRR)
		Tufts Medical Center